168 related articles for article (PubMed ID: 2573090)
1. Antibiotics: opportunities for genetic manipulation.
Hopwood DA
Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):549-62. PubMed ID: 2573090
[TBL] [Abstract][Full Text] [Related]
2. Fresh approaches to antibiotic production.
Hopwood DA; Chater KF
Philos Trans R Soc Lond B Biol Sci; 1980 Aug; 290(1040):313-28. PubMed ID: 6106246
[TBL] [Abstract][Full Text] [Related]
3. Genetic manipulation of antibiotic-producing microorganisms.
Vournakis JN; Elander RP
Science; 1983 Feb; 219(4585):703-9. PubMed ID: 6572018
[TBL] [Abstract][Full Text] [Related]
4. Second-generation products: antibiotics.
Fayerman JT
Bioprocess Technol; 1991; 13():415-24. PubMed ID: 1367143
[TBL] [Abstract][Full Text] [Related]
5. [Gene networks that regulate secondary metabolism in actinomycetes: pleiotropic regulators].
Rabyk MV; Ostash BO; Fedorenko VO
Tsitol Genet; 2014; 48(1):67--82. PubMed ID: 24791475
[TBL] [Abstract][Full Text] [Related]
6. Structure alteration of polyketides by recombinant DNA technology in producer organisms--prospects for the generation of novel pharmaceutical drugs.
Méndez C; Weitnauer G; Bechthold A; Salas JA
Curr Pharm Biotechnol; 2000 Dec; 1(4):355-95. PubMed ID: 11467332
[TBL] [Abstract][Full Text] [Related]
7. Production of 'hybrid' antibiotics by genetic engineering.
Hopwood DA; Malpartida F; Kieser HM; Ikeda H; Duncan J; Fujii I; Rudd BA; Floss HG; Omura S
Nature; 1985 Apr 18-24; 314(6012):642-4. PubMed ID: 3857464
[TBL] [Abstract][Full Text] [Related]
8. Clavulanic acid production by Streptomyces clavuligerus: biogenesis, regulation and strain improvement.
Paradkar A
J Antibiot (Tokyo); 2013 Jul; 66(7):411-20. PubMed ID: 23612724
[TBL] [Abstract][Full Text] [Related]
9. Genetic manipulation of antibiotic-producing Streptomyces.
Baltz RH
Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
[TBL] [Abstract][Full Text] [Related]
10. Production of novel chemotherapeutic drugs by Streptomycetes.
Rassi H; Ghasemi SF
Lik Sprava; 2008; (7-8):40-7. PubMed ID: 19663015
[TBL] [Abstract][Full Text] [Related]
11. Clavulanic acid biosynthesis and genetic manipulation for its overproduction.
Song JY; Jensen SE; Lee KJ
Appl Microbiol Biotechnol; 2010 Oct; 88(3):659-69. PubMed ID: 20711575
[TBL] [Abstract][Full Text] [Related]
12. Genetic engineering of antibiotic biosynthesis for the generation of new aminocoumarins.
Heide L
Biotechnol Adv; 2009; 27(6):1006-1014. PubMed ID: 19463934
[TBL] [Abstract][Full Text] [Related]
13. Large-Scale Transposition Mutagenesis of Streptomyces coelicolor Identifies Hundreds of Genes Influencing Antibiotic Biosynthesis.
Xu Z; Wang Y; Chater KF; Ou HY; Xu HH; Deng Z; Tao M
Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28062460
[TBL] [Abstract][Full Text] [Related]
14. Homology between Streptomyces genes coding for synthesis of different polyketides used to clone antibiotic biosynthetic genes.
Malpartida F; Hallam SE; Kieser HM; Motamedi H; Hutchinson CR; Butler MJ; Sugden DA; Warren M; McKillop C; Bailey CR
Nature; 1987 Feb 26-Mar 4; 325(6107):818-21. PubMed ID: 3029594
[TBL] [Abstract][Full Text] [Related]
15. Production of beta-lactam antibiotics and its regulation.
Demain AL
Proc Natl Sci Counc Repub China B; 1991 Oct; 15(4):251-65. PubMed ID: 1815263
[TBL] [Abstract][Full Text] [Related]
16. Synthetic biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production.
Wohlleben W; Mast Y; Muth G; Röttgen M; Stegmann E; Weber T
FEBS Lett; 2012 Jul; 586(15):2171-6. PubMed ID: 22710162
[TBL] [Abstract][Full Text] [Related]
17. Nature's combinatorial biosynthesis and recently engineered production of nucleoside antibiotics in Streptomyces.
Chen S; Kinney WA; Van Lanen S
World J Microbiol Biotechnol; 2017 Apr; 33(4):66. PubMed ID: 28260195
[TBL] [Abstract][Full Text] [Related]
18. Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics.
Miao V; Coëffet-Le Gal MF; Nguyen K; Brian P; Penn J; Whiting A; Steele J; Kau D; Martin S; Ford R; Gibson T; Bouchard M; Wrigley SK; Baltz RH
Chem Biol; 2006 Mar; 13(3):269-76. PubMed ID: 16638532
[TBL] [Abstract][Full Text] [Related]
19. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
20. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
